These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32886204)

  • 1. Hepatobiliary phase enhancement of liver metastases on gadoxetic acid MRI: assessment of frequency and patterns.
    Bhayana R; Baliyan V; Kordbacheh H; Kambadakone A
    Eur Radiol; 2021 Mar; 31(3):1359-1366. PubMed ID: 32886204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
    Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
    Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatobiliary contrast uptake patterns on gadoxetic acid-enhanced MRI in liver metastases from pancreatic ductal adenocarcinoma: can it predict prognosis?
    Noda Y; Tochigi T; Baliyan V; Kordbacheh H; Kambadakone A
    Eur Radiol; 2021 Jan; 31(1):276-282. PubMed ID: 32783131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a "defect" on the hepatobiliary phase.
    Kim A; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
    Eur J Radiol; 2012 Dec; 81(12):3998-4004. PubMed ID: 22921889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma.
    Bilreiro C; Soler JC; Ayuso JR; Caseiro-Alves F; Ayuso C
    Radiol Med; 2021 Nov; 126(11):1379-1387. PubMed ID: 34287759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI.
    Hui CL; Mautone M
    Br J Radiol; 2020 Aug; 93(1112):20190989. PubMed ID: 32462892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abbreviated Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Adenocarcinoma.
    Yamaguchi T; Sofue K; Ueshima E; Ueno Y; Tsujita Y; Yabe S; Shirakawa S; Toyama H; Hori M; Fukumoto T; Murakami T
    J Magn Reson Imaging; 2022 Sep; 56(3):725-736. PubMed ID: 35005813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI.
    Palm V; Sheng R; Mayer P; Weiss KH; Springfeld C; Mehrabi A; Longerich T; Berger AK; Kauczor HU; Weber TF
    Cancer Imaging; 2018 Mar; 18(1):9. PubMed ID: 29490696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase in the evaluation of hepatic metastasis from breast cancer: is the "target sign" a common finding?
    Ha S; Lee CH; Kim BH; Park YS; Lee J; Choi JW; Kim KA; Park CM
    Magn Reson Imaging; 2012 Oct; 30(8):1083-90. PubMed ID: 22578929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.
    Khouri Chalouhi C; Vernuccio F; Rini F; Duca P; Tuscano B; Brancatelli G; Vanzulli A
    Eur Radiol; 2019 Jun; 29(6):3090-3099. PubMed ID: 30547205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.
    Yeom SK; Byun JH; Kim HJ; Park SH; Kim N; Shin YM; Kim PN
    Magn Reson Imaging; 2013 Jul; 31(6):911-7. PubMed ID: 23598063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and quantitative parameters on hepatobiliary phase of gadoxetic acid-enhanced MR imaging for predicting pathological response to preoperative systemic therapy in colorectal liver metastases.
    Gu XL; Cui Y; Wang K; Xing Q; Li XT; Zhu HT; Li ZW; Sun YS
    Eur J Radiol; 2022 Dec; 157():110572. PubMed ID: 36327859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of OATP1B3 in colorectal cancer liver metastases and its clinical implication on gadoxetic acid-enhanced MRI.
    Park SH; Kim H; Kim EK; Kim H; Choi DK; Chung YE; Kim MJ; Choi JY
    Oncotarget; 2017 Sep; 8(41):71012-71023. PubMed ID: 29050339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Nondefect" of arterial enhancing rim on hepatobiliary phase in 3.0-T gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced liver magnetic resonance imaging: distinguishing hepatic abscess from metastasis.
    Choi SH; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
    J Comput Assist Tomogr; 2013; 37(6):849-55. PubMed ID: 24270105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
    Kim TH; Woo S; Ebrahimzadeh S; McInnes MDF; Gerst SR; Do RK
    AJR Am J Roentgenol; 2023 Jan; 220(1):28-38. PubMed ID: 35920706
    [No Abstract]   [Full Text] [Related]  

  • 16. Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX.
    Wang X; Wang Y; Zhang Z; Zhou M; Zhou X; Zhao H; Xing J; Zhou Y
    Eur J Radiol; 2021 Oct; 143():109887. PubMed ID: 34454297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatobiliary phase imaging in cirrhotic patients using compressed sensing and controlled aliasing in parallel imaging results in higher acceleration.
    Yoon S; Shim YS; Park SH; Sung J; Nickel MD; Kim YJ; Lee HY; Kim HJ
    Eur Radiol; 2024 Apr; 34(4):2233-2243. PubMed ID: 37731096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
    Kang Y; Lee JM; Kim SH; Han JK; Choi BI
    Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
    Granata V; Catalano O; Fusco R; Tatangelo F; Rega D; Nasti G; Avallone A; Piccirillo M; Izzo F; Petrillo A
    Abdom Imaging; 2015 Oct; 40(7):2364-71. PubMed ID: 26105523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
    Kim SS; Kim SH; Song KD; Choi SY; Heo NH
    J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.